HI
MYGN icon

Harbour Investments’s Myriad Genetics MYGN Stock Holding History

Harbour Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88K Hold
680
– – ﹤0.01% 3795
2026
Q1 		$3.06K Buy
680
+180
+36% +$938 ﹤0.01% 3772
2025
Q4 		$3.08K Hold
500
– – ﹤0.01% 3190
2025
Q3 		$3.62K Hold
500
– – ﹤0.01% 3097
2025
Q2 		$2.65K Hold
500
– – ﹤0.01% 3054
2025
Q1 		$4.43K Buy
+500
New +$6K ﹤0.01% 2863
2021
Q4 		– Sell
-430
Closed -$14K – 3308
2021
Q3 		$14K Sell
430
-18
-4% -$598 ﹤0.01% 2493
2021
Q2 		$14K Hold
448
– – ﹤0.01% 2548
2021
Q1 		$14K Buy
+448
New +$12.7K ﹤0.01% 2416

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbour Investments's MYGN Position: Q2 2026 in Review

Harbour Investments held its Myriad Genetics (MYGN) position steady in Q2 2026 at 680 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3795.

Harbour Investments first reported a position in MYGN in Q1 2021 and has held it in 9 quarters since. The position peaked at $14K in Q3 2021. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Harbour Investments held 680 shares of Myriad Genetics worth $3.88K as of Q2 2026.
  • Harbour Investments left its Myriad Genetics share count unchanged in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3795 holding.
  • Harbour Investments first reported a position in Myriad Genetics in Q1 2021 and has held it in 9 quarters since.
  • Harbour Investments's Myriad Genetics position peaked at $14K in Q3 2021.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.